|
Status |
Public on Feb 20, 2015 |
Title |
PB-Cre Ptenlox/lox 12 mo_P191 |
Sample type |
genomic |
|
|
Channel 1 |
Source name |
PB-Cre Ptenlox/lox (129/Bl6)
|
Organism |
Mus musculus |
Characteristics |
strain: 129/Bl6 tissue: prostate cancer gender: male gem model of prostate cancer: Pten-/-
|
Treatment protocol |
no treatment
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was prepared using the Qiagen DNA easy kit
|
Label |
Cy5
|
Label protocol |
starting 3ug DNA and following Agilent standard cy5/cy3 labeling protocols.
|
|
|
Channel 2 |
Source name |
control (wild-type littermate)
|
Organism |
Mus musculus |
Characteristics |
strain: 129/Bl6 genotype/variation: wild-type
|
Treatment protocol |
no treatment
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was prepared using the Qiagen DNA easy kit
|
Label |
Cy3
|
Label protocol |
starting 3ug DNA and following Agilent standard cy5/cy3 labeling protocols.
|
|
|
|
Hybridization protocol |
hybridize the arrays at 20rpm of 65C for 40 hours following Agilent instruction.
|
Scan protocol |
Slides were scanned using the Agilent Scanner with the standard protocols.
|
Description |
P191 CGH data
|
Data processing |
The raw data were extracted with Feature Extraction using Agilent default analysis settings.
|
|
|
Submission date |
Sep 12, 2014 |
Last update date |
Feb 20, 2015 |
Contact name |
Jeffrey Zhao |
Organization name |
Memorial Sloan Kettering Cancer Center
|
Department |
Genomics Core
|
Street address |
1275 York Avenue
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platform ID |
GPL15076 |
Series (2) |
GSE61382 |
Identifying actionable targets through integrative analyses of GEM model and human prostate cancer profiling [Agilent] |
GSE61383 |
Identifying actionable targets through integrative analyses of GEM model and human prostate cancer profiling |
|